BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 18, 2026
Home » Newsletters » BioWorld

BioWorld

March 5, 2012

View Archived Issues

Congress Seeks Answers to Growing Rx Drug Abuse

WASHINGTON – With the misuse and abuse of drugs becoming the leading cause of accidental death in the U.S., Congress is looking for ways to curb the use of some prescription painkillers and insomnia/anxiety drugs. Read More

Bench Press

HIV infects CD4 "helper" T cells. But new research out of the Massachusetts Institute of Technology's Ragon Institute showed that early in the course of HIV infection, helper T cells play a greater role in controlling the disease than has been appreciated. Read More

Appointments and Advancements

• Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed Jeff Riley president and CEO, added C. Evan Ballantyne as chief financial officer and named Scott L. Tarriff and Nelson K. Stacks to the board. Read More

Pharma: Other News To Note

• Baxter International Inc., of Deerfield, Ill., said the European Commission granted marketing authorization of Vepacel, a pre-pandemic influenza vaccine indicated for active immunization in adults, ages 18 and older, against the H5N1 subtype of influenza A. Read More

Clinic Roundup

• Novavax Inc., of Rockville, Md., said it started enrollment in a Phase II trial of its quadrivalent seasonal influenza virus-like particle vaccine candidate. The study, being conducted under the firm's contract with the Department of Health and Human Services' Office of Biomedical Advanced Research and Development Authority, is designed to evaluate the immunogenicity and safety of three dose levels of the vaccine in healthy adults, ages 18 to 64. Read More

Stock Movers

Read More

Amicus Doubles Cash in $57M Offering; Amigal Data in 3Q12

Awaiting much-anticipated data from its pivotal Fabry disease program later this year, Amicus Therapeutics Inc. is doubling its cash balance via a $57 million public offering. Read More

Other News To Note

• Columbia Laboratories Inc., of Livingston, N.J., said it's cutting its work force by about 42 percent, from 24 employees to 14 employees, primarily in R&D and general administrative positions, to lower costs and better align operating expenses with revenues. Read More

No HAHAs for Xbiotech's Novel Antibodies, Production Method

Antibodies have come a long way. But Austin, Texas-based biopharmaceutical firm Xbiotech Inc. wants to take them further still. Read More

Start-up TremRx Thinks Best Immunity Is Only Skin Deep

Vaccines are now given as an intramuscular jab. And that delivery, Thomas Kupper told BioWorld Today, "totally bypasses the rich immunological environment of the skin.". Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing